These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4625982)

  • 21. Plasma amantadine concentrations in patients with Parkinson's disease.
    Nishikawa N; Nagai M; Moritoyo T; Yabe H; Nomoto M
    Parkinsonism Relat Disord; 2009 Jun; 15(5):351-3. PubMed ID: 18823813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled trial of amantadine hydrochloride in Parkinson's disease.
    Jorgensen PB; Bergin JD; Haas L; Cuningham JA; Morah DD; Pollock M; Robinson RG; Spears GF
    N Z Med J; 1971 May; 73(468):263-7. PubMed ID: 4932146
    [No Abstract]   [Full Text] [Related]  

  • 23. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
    Gerstenbrand F; Grünberger J; Oberhummer I
    HNO; 1970 Nov; 18(11):390-7. PubMed ID: 5512006
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
    Gerstenbrand F; Grünberger J; Oberhummer I
    Wien Med Wochenschr; 1971 May; 121(19):390-7. PubMed ID: 5559920
    [No Abstract]   [Full Text] [Related]  

  • 25. Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease.
    Silver DE; Sahs AL
    Trans Am Neurol Assoc; 1971; 96():307-8. PubMed ID: 4945919
    [No Abstract]   [Full Text] [Related]  

  • 26. [Adamantylamine sulfate--a drug for treatment of Parkinson's disease with a new working principle].
    Fünfgeld EW
    Med Klin; 1970 Sep; 65(39):1703-6. PubMed ID: 5474341
    [No Abstract]   [Full Text] [Related]  

  • 27. Amantadine induced reversible corneal edema.
    Deogaonkar M; Wilson K; Vitek J
    J Clin Neurosci; 2011 Feb; 18(2):298-9. PubMed ID: 21163653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug therapy of Parkinson's diseases].
    Lhermitte F; Degos CF
    Acquis Med Recent; 1972; ():73-80. PubMed ID: 4667798
    [No Abstract]   [Full Text] [Related]  

  • 29. Amantadine hydrochloride in the treatment of Parkinson's disease.
    Nagaswami S; Ranjini R
    J Kans Med Soc; 1971 Nov; 72(11):465-8. PubMed ID: 5120698
    [No Abstract]   [Full Text] [Related]  

  • 30. [Circulatory disorders induced by amantidine].
    Cloarec M; Singer B; Mignot B; Contamin F; Graisely B; Debray J
    Sem Hop; 1976 Apr; 52(14):889-93. PubMed ID: 188158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Amantadine treatment in Parkinson's disease].
    Boman K; Kivalo E; Porras J
    Nord Med; 1970 Nov; 84(48):1518-20. PubMed ID: 4922228
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient].
    Ceballos-Baumann AO
    MMW Fortschr Med; 2002 May; Suppl 2():37-43. PubMed ID: 12070848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Medical treatment of Parkinson's disease with amantadine hydrochloride. Preliminary note].
    Portera A; Varela de Seijas E; Mata P; Ramírez Echevarría TJ; Amaya Pombo C
    Rev Clin Esp; 1970 Jun; 117(6):579-86. PubMed ID: 5518942
    [No Abstract]   [Full Text] [Related]  

  • 34. [Edemas and myocloni concerning a patient with Parkinson's disease treated by amantadine (author's transl)].
    Chevalier JF; Renier E; Brion S
    Encephale; 1980; 6(4):381-4. PubMed ID: 7439114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Amantadine in the treatment of Parkinson's syndrome: studied in 31 patients for 3 months].
    Campanella G; Zallone E; Buscaino GA
    Acta Neurol (Napoli); 1972; 27(5):491-500. PubMed ID: 4564842
    [No Abstract]   [Full Text] [Related]  

  • 36. Corneal endothelial dysfunction associated with amantadine toxicity.
    Chang KC; Kim MK; Wee WR; Lee JH
    Cornea; 2008 Dec; 27(10):1182-5. PubMed ID: 19034138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment options for early Parkinson's disease.
    Stacy M; Brownlee HJ
    Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Amantadine in Parkinson's disease].
    Streifler M; Kallay U
    Harefuah; 1972 Jun; 82(11):499-503. PubMed ID: 5068899
    [No Abstract]   [Full Text] [Related]  

  • 39. Twenty-five years of amantadine therapy in Parkinson's disease.
    Danielczyk W
    J Neural Transm Suppl; 1995; 46():399-405. PubMed ID: 8821075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amantadine and other antiglutamate agents: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S13-22. PubMed ID: 12211136
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.